Grant: Operating Grant
McMaster University
$569,230.00
The Role of ADAM17 in the Pathogenesis of Diabetic Nephropathy
FY 2011-12
Summary
Diabetes is the most common cause of kidney failure. In the diabetic kidney, scar proteins (matrix) accumulate in the filtering units (glomeruli) and prevent them from functioning properly. It is not yet known how high glucose levels cause glomerulus (mesangial) cells to produce matrix. Our recent studies have shown that in mesangial cells exposed to high glucose, the protein ADAM17 is activated and involved in matrix production by causing the activation of the epidermal growth factor receptor (EGFR). We have previously shown that EGFR activation by high glucose leads mesangial cells to produce matrix proteins. I plan to investigate exactly how ADAM17 is activated by high glucose, and whether blocking its activation with drugs can slow or prevent the development of kidney disease in a rat model of diabetes. If effective, this would be a potential new treatment for people whose diabetes has affected their kidneys.
Department
Program
Operating Grant
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
237912
Name
Krepinsky Joan
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Hematology, Digestive Disease & Kidney
Projecttitle
The Role of ADAM17 in the Pathogenesis of Diabetic Nephropathy
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$569,230
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Animal Studies; Diabetic Nephropathy; Extracellular Matrix; Mesangial Cell; Signaling; Transfection
Abstract
Diabetes is the most common cause of kidney failure. In the diabetic kidney, scar proteins (matrix) accumulate in the filtering units (glomeruli) and prevent them from functioning properly. It is not yet known how high glucose levels cause glomerulus (mesangial) cells to produce matrix. Our recent studies have shown that in mesangial cells exposed to high glucose, the protein ADAM17 is activated and involved in matrix production by causing the activation of the epidermal growth factor receptor (EGFR). We have previously shown that EGFR activation by high glucose leads mesangial cells to produce matrix proteins. I plan to investigate exactly how ADAM17 is activated by high glucose, and whether blocking its activation with drugs can slow or prevent the development of kidney disease in a rat model of diabetes. If effective, this would be a potential new treatment for people whose diabetes has affected their kidneys.
Competitiondate
201109
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Krepinsky, Joan
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $569,230~ $0~